Apel­lis soars as Alex­ion ri­val out­shines block­buster stan­dard bear­er Soliris — then fresh doubts scut­tle spike

Apel­lis went gun­ning for Alex­ion’s star drug Soliris in a head-to-head PNH Phase III. And the small­er biotech said Tues­day morn­ing that they came out with a clear win.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER